Blocking the renin–angiotensin system: dual-versus mono-therapy

A Ravandi, KK Teo - Expert Review of Cardiovascular Therapy, 2009 - Taylor & Francis
The renin–angiotensin system (RAS) plays an important role in the pathogenesis of
cardiovascular disease. One of the effects of the activated RAS is target-organ damage, in …
被引用次数：26 相关文章

Blocking the renin-angiotensin system: dual-versus mono-therapy

A Ravandi, KK Teo - Expert review of cardiovascular …, 2009 - pubmed.ncbi.nlm.nih.gov
The renin-angiotensin system (RAS) plays an important role in the pathogenesis of
cardiovascular disease. One of the effects of the activated RAS is target-organ damage, in …

Blocking the renin-angiotensin system: dual-versus mono-therapy.

A Ravandi, KK Teo - Expert Review of Cardiovascular Therapy, 2009 - europepmc.org
The renin-angiotensin system (RAS) plays an important role in the pathogenesis of
cardiovascular disease. One of the effects of the activated RAS is target-organ damage, in …

Blocking the renin-angiotensin system: dual-versus mono-therapy

A Ravandi, KK Teo - Expert Review of Cardiovascular Therapy, 2009 - go.gale.com
Cardiovascular (CV) disease represents the most common cause of morbidity and mortality
worldwide. Many of the risk factors attributed to CV disease exert their effects along a …

Blocking the renin-angiotensin system: dual-versus mono-therapy

A Ravandi, KK Teo - Expert Review of Cardiovascular …, 2009 - search.proquest.com
The renin-angiotensin system (RAS) plays an important role in the pathogenesis of
cardiovascular disease. One of the effects of the activated RAS is target-organ damage, in …

[引用][C] Blocking the renin–angiotensin system: dual-versus mono-therapy

A Ravandi, KK Teo - Expert Review of Cardiovascular Therapy, 2009 - cir.nii.ac.jp
Blocking the renin–angiotensin system: dual- versus mono-therapy | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …